These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34110506)

  • 21. Syringe Services Programs to Reduce Intravenous Disease Transmission in Substance Use Disorders.
    Roberts HH; Stone M; Isac AJ
    Nurs Clin North Am; 2023 Jun; 58(2):243-256. PubMed ID: 37105658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation.
    Jakubowski A; Rath C; Harocopos A; Wright M; Welch A; Kattan J; Navos Behrends C; Lopez-Castro T; Fox AD
    Harm Reduct J; 2022 Jul; 19(1):75. PubMed ID: 35818071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weathering the Storm: Syringe Services Program Laws and Human Immunodeficiency Virus During the COVID-19 Pandemic.
    Jackson H; Dunphy C; Grist MB; Jiang X; Xu L; Guy GP; Salvant-Valentine S
    J Acquir Immune Defic Syndr; 2023 Dec; 94(5):395-402. PubMed ID: 37949442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A qualitative analysis of rural syringe service program fidelity in Appalachian Kentucky: Staff and participant perspectives.
    Batty EJ; Ibragimov U; Fadanelli M; Gross S; Cooper K; Klein E; Ballard AM; Young AM; Lockard AS; Oser CB; Cooper HLF
    J Rural Health; 2023 Mar; 39(2):328-337. PubMed ID: 36117151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
    Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ
    Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Program Director Reports of COVID-19 Lockdown-Driven Service Changes in Community-Based STI Clinics and Syringe Services Programs in the Southeastern U.S.
    Hatch MA; Laschober TC; Ertl MM; Paschen-Wolff MM; Norman G; Wright L; Tross S
    AIDS Educ Prev; 2024 Apr; 36(2):129-140. PubMed ID: 38648174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective.
    van Santen DK; Coutinho RA; van den Hoek A; van Brussel G; Buster M; Prins M
    Harm Reduct J; 2021 Jan; 18(1):2. PubMed ID: 33407562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
    Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
    Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff.
    Aronson ID; Bennett AS; Freeman R
    Harm Reduct J; 2020 Oct; 17(1):77. PubMed ID: 33076911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine.
    Corcorran MA; Austin EJ; Behrends CN; Briggs ES; Frost MC; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    J Addict Med; 2023 Jan-Feb 01; 17(1):e36-e41. PubMed ID: 35916422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capacity for sustainment of recently established syringe service programs in Appalachian Kentucky: The central role of staff champions.
    Cooper HLF; Gross S; Klein E; Fadanelli M; Ballard A; Lockard S; Batty E; Young A; Ibragimov U
    Drug Alcohol Rev; 2022 May; 41(4):863-872. PubMed ID: 35112747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives.
    McCrimmon T; Sundelson A; Darisheva M; Gilbert L; Hunt T; Terlikbayeva A; Primbetova S; El-Bassel N
    Glob Health Sci Pract; 2022 Apr; 10(2):. PubMed ID: 35487549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs.
    Adams M; An Q; Broz D; Burnett J; Wejnert C; Paz-Bailey G;
    AIDS Behav; 2019 Dec; 23(12):3306-3314. PubMed ID: 31512066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
    Syvertsen JL; Pollini RA
    Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early disruptions to syringe services programs during the Russian invasion of Ukraine.
    Nikitin BM; Bromberg DJ; Pykalo I; Ivasiy R; Islam Z; Altice FL
    Front Public Health; 2023; 11():1229057. PubMed ID: 38074770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syringe services programs and real-world research: An overview for pharmacists.
    Carico RR; Hussain N; Sheppard J; Thomas CB; Fenerty J
    J Am Pharm Assoc (2003); 2020; 60(5):e29-e33. PubMed ID: 32278515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "We're actually more of a likely ally than an unlikely ally": relationships between syringe services programs and law enforcement.
    Franco CY; Lee-Winn AE; Brandspigel S; Alishahi ML; Brooks-Russell A
    Harm Reduct J; 2021 Aug; 18(1):81. PubMed ID: 34348714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.